Invesco’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-825,103
| Closed | -$42.6M | – | 4105 |
|
|
2022
Q3 | $42.6M | Sell |
825,103
-896,091
| -52% | -$37M | 0.01% | 964 |
|
|
2022
Q2 | $42.7M | Buy |
1,721,194
+110,203
| +7% | +$2.43M | 0.01% | 983 |
|
|
2022
Q1 | $40.4M | Buy |
1,610,991
+392,803
| +32% | +$11M | 0.01% | 1094 |
|
|
2021
Q4 | $44.4M | Buy |
1,218,188
+164,864
| +16% | +$5.79M | 0.01% | 1097 |
|
|
2021
Q3 | $18M | Buy |
1,053,324
+387,311
| +58% | +$6.03M | ﹤0.01% | 1629 |
|
|
2021
Q2 | $8.92M | Sell |
666,013
-11,027
| -2% | -$272K | ﹤0.01% | 2125 |
|
|
2021
Q1 | $34.7M | Sell |
677,040
-295,643
| -30% | -$17.8M | 0.01% | 1227 |
|
|
2020
Q4 | $60.2M | Buy |
972,683
+272,350
| +39% | +$15.6M | 0.02% | 956 |
|
|
2020
Q3 | $38.4M | Buy |
700,333
+489,590
| +232% | +$26.4M | 0.01% | 1033 |
|
|
2020
Q2 | $12.1M | Sell |
210,743
-105,490
| -33% | -$5.74M | ﹤0.01% | 1532 |
|
|
2020
Q1 | $12.7M | Buy |
316,233
+154,265
| +95% | +$6.55M | 0.01% | 1423 |
|
|
2019
Q4 | $6.41M | Buy |
161,968
+11,357
| +8% | +$199K | ﹤0.01% | 2018 |
|
|
2019
Q3 | $1.02M | Sell |
150,611
-11,112
| -7% | -$83.4K | ﹤0.01% | 2994 |
|
|
2019
Q2 | $1.5M | Buy |
161,723
+12,735
| +9% | +$147K | ﹤0.01% | 2851 |
|
|
2019
Q1 | $2.07M | Buy |
148,988
+5,154
| +4% | +$58.9K | ﹤0.01% | 2591 |
|
|
2018
Q4 | $1.57M | Buy |
143,834
+7,707
| +6% | +$81.3K | ﹤0.01% | 2708 |
|
|
2018
Q3 | $1.72M | Buy |
136,127
+96,845
| +247% | +$1.17M | ﹤0.01% | 2861 |
|
|
2018
Q2 | $517K | Sell |
39,282
-9,983
| -20% | -$119K | ﹤0.01% | 3411 |
|
|
2018
Q1 | $670K | Sell |
49,265
-28,395
| -37% | -$293K | ﹤0.01% | 3217 |
|
|
2017
Q4 | $462K | Sell |
77,660
-38,102
| -33% | -$261K | ﹤0.01% | 3333 |
|
|
2017
Q3 | $859K | Buy |
115,762
+5,070
| +5% | +$42.1K | ﹤0.01% | 3091 |
|
|
2017
Q2 | $1.04M | Sell |
110,692
-134,356
| -55% | -$986K | ﹤0.01% | 2992 |
|
|
2017
Q1 | $1.78M | Buy |
245,048
+266
| +0.1% | +$1.92K | ﹤0.01% | 2666 |
|
|
2016
Q4 | $1.81M | Buy |
244,782
+196,651
| +409% | +$1.42M | ﹤0.01% | 2651 |
|
|
2016
Q3 | $291K | Buy |
+48,131
| New | +$227K | ﹤0.01% | 3438 |
|
|
2015
Q3 | – | Sell |
-625
| Closed | -$5K | – | 4071 |
|
|
2015
Q2 | $5K | Sell |
625
-9,962
| -94% | -$79.1K | ﹤0.01% | 4238 |
|
|
2015
Q1 | $80K | Buy |
+10,587
| New | +$82.7K | ﹤0.01% | 3827 |
|
Other funds holding CCXI
Invesco's CCXI Position: Q4 2022 in Review
Invesco sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 825,103 shares — an estimated $42.6M sold.
Invesco first reported a position in CCXI in Q1 2015 and held it in 27 quarters. The position peaked at $60.2M in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Invesco reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Invesco sold 825,103 ChemoCentryx, Inc. shares in Q4 2022, an estimated $42.6M.
- Invesco first reported a position in ChemoCentryx, Inc. in Q1 2015 and held it in 27 quarters.
- Invesco's ChemoCentryx, Inc. position peaked at $60.2M in Q4 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Invesco's 13F filing for Q4 2022, filed 13 Feb 2023.